| # | Drug | Count |
|---|---|---|
| 0 | QUETIAPINE | 23 |
| 1 | LEVONORGESTREL | 20 |
| 2 | RISPERIDONE | 18 |
| 3 | OLANZAPINE | 14 |
| 4 | ARIPIPRAZOLE | 13 |
| 5 | ESTRADIOL | 12 |
| 6 | LEVOTHYROXINE SODIUM | 12 |
| 7 | PALIPERIDONE PALMITATE | 12 |
| 8 | BUPROPION HYDROCHLORIDE | 8 |
| 9 | CLONAZEPAM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0049 |
| 1 | BROMOCRIPTINE MESYLATE | 3 | 0.0046 |
| 2 | DROSPIRENONE AND ESTRADIOL | 2 | 0.0037 |
| 3 | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 1 | 0.0025 |
| 4 | BETHANECHOL CHLORIDE | 1 | 0.0018 |
| 5 | CONJUGATED ESTROGENS/BAZEDOXIFENE | 1 | 0.0011 |
| 6 | OMEPRAZOLE, SODIUM BICARBONATE | 1 | 0.0010 |
| 7 | ESTRADIOL/NORETHINDRONE ACETATE | 2 | 0.0010 |
| 8 | ZIPRASIDONE | 3 | 0.0008 |
| 9 | NARATRIPTAN | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 52 |
| 1 | Progestin [EPC] | 25 |
| 2 | Estrogen [EPC] | 23 |
| 3 | Progestin-containing Intrauterine System [EPC] | 21 |
| 4 | Benzodiazepine [EPC] | 17 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 6 | Proton Pump Inhibitor [EPC] | 9 |
| 7 | Vitamin C [EPC] | 9 |
| 8 | Anti-epileptic Agent [EPC] | 8 |
| 9 | Provitamin D2 Compound [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 3 | 0.0004 |
| 1 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 2 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 3 | Estrogen [EPC] | 23 | 0.0001 |
| 4 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 3 | 0.0001 |
| 5 | Atypical Antipsychotic [EPC] | 52 | 0.0001 |
| 6 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 7 | Parathyroid Hormone-Related Peptide Analog [EPC] | 3 | 0.0001 |
| 8 | Bile Acid [EPC] | 2 | 0.0001 |
| 9 | Progestin [EPC] | 25 | 0.0001 |